Quest Diagnostics(NYSE) DGX

Quest Diagnostics NYSE:DGX helps people understand health through laboratory testing. It turns medical samples into insights for doctors and patients. These services help identify disease and guide treatment choices.

Tests, Tools, and Tech

• Diagnostic Information Services: Provides lab testing insights for physicians, hospitals, and patients; accounts for greater than 95% of revenue.
• Diagnostic Solutions: Offers risk assessment tools for insurers and information technology for healthcare providers; represents the balance of revenue.

Strategic Moves and Modernization

• Formed a venture with Corewell Health in Michigan during January 2026 to operate a joint laboratory facility.
• Expanded laboratory testing at United States dialysis clinics owned by Fresenius Medical Care.
• Executed the multiyear Invigorate program to drive 3% annual cost savings through automation and artificial intelligence.
• Launched Project Nova in February 2025 to modernize business processes and information technology infrastructure.

Data and Expertise at Scale

Quest Diagnostics uses one of the largest databases of clinical laboratory results to reveal new ways to identify and treat disease. It supports these insights with a team of medical experts, including geneticists and scientific directors, who consult with healthcare providers. This scale allows the company to serve physicians, hospitals, health plans, and employers through a nationwide network of laboratories and patient service centers.

The Latest Financial Facts

• Total net revenues were $3.1 billion for the three months ended Sept. 30, 2026, up 10% year over year.
• Operating income reached $479 million for the three months ended Sept. 30, 2026, up 24.2% year over year.
• Net income was $312 million for the three months ended Sept. 30, 2026, up 27.6% year over year.
• Diluted earnings per share reached $2.78 for the three months ended Sept. 30, 2026, up 28.7% year over year.

Bottom Line

Quest Diagnostics has evolved from a routine laboratory provider into a data-focused health information company. Its focus on automation and technology modernization supports long-term efforts to improve productivity and the digital experience for patients.